Aston Chemicals Ltd.

AcceleDev is a small molecule development & production company, with a staff of 100 people. Global operations include R&D & manufacturing sites in USA & China. Business specialties in the areas of "custom synthesis of advances intermediates"​ & "qualification/supply of raw materials"​, primarily in support of Pharmaceutical API programs.

AGC Chemicals Americas is a wholly owned subsidiary of AGC Inc., a $14 billion multinational corporation and one of the world’s largest manufacturers of glass, electronic displays and chemical products.

AGC Chemicals Americas, Inc. manufactures, markets and sells fluoroproducts including Fluon® fluoropolymer resins, Fluon+™ enhanced fluorinated materials and compounds, AFLAS® fluoroelastomers and AsahiKlin fluorinated solvents. The company also markets and sells specialty chemicals and materials including LUMIFLON® FEVE resins, AsahiGuard E-SERIES water and oil repellants, Fluon ETFE film, F-CLEAN® greenhouse films, Solesphere™ fine silica additives and various fluoro intermediates for pharma and agro products.

AGC Chemicals Americas was formed in 2004 through the merging of sister companies Asahi Glass Fluoropolymers USA and AGA Chemicals. Headquartered in Exton, Pa., including a state-of-the-art technology center, AGC Chemicals Americas maintains manufacturing operations in nearby Thorndale, Pa., a satellite sales office in Sao Paulo, Brazil and warehouses located throughout North America.

We are pleased to offer R&D services and technical support from our Business and Technical Center as part of our business development and technical solutions strategies.

Our mission can be summarized in the following phrase: "Your Dreams, Our Challenge."​ Working with others to combine knowledge and advanced technology, we create unique materials, solutions and reliable partnerships that help make ever greater achievements possible, and bring bolder ideas to life.

We invite you to further explore our web site to see how products from AGC Chemicals Americas can make a difference in your businesses.

Founded in 1967, Balchem is committed to making the world a healthier place by delivering trusted, innovative, and science-based solutions to the nutrition, health, and food markets. We provide the service, quality, and technology that enables our customers to win with their customers. As a publicly traded company listed on the NASDAQ under BCPC, Balchem has built a reputation over the years of delivering results to our stakeholders. Our corporate headquarters is located in New Hampton, New York (Hudson Valley area), and we have a broad network of sales offices, manufacturing sites, and R&D centers, primarily located in the US and Europe. Balchem consists of three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Balchem employs over 1,400 people worldwide who are engaged in diverse activities, committed to developing the company into global market leadership positions.

Visit our website at www.balchem.com to learn more about us and the exciting opportunities we have available!

BLIRT (Biolab Innovative Research Technologies) is a modern European biotech manufacturer of high quality specialty enzymes and reagents dedicated for application in Life Science.

For over 25 years, BLIRT has been specializing in providing the highest quality products for researchers and scientists. Since 1994, the company began operating in the Polish market as DNA-Gdańsk. From 2007, the company developed and further expanded brand as BLIRT.
A brand new manufacturing facility, commissioned in the late fall of 2017, allows BLIRT to deliver kilogram quantities of any protein expressed in yeast, or bacteria. Every protein in BLIRT’s portfolio is free of any third party IP.

BLIRT also manufactures and sells convenient kits for DNA/RNA isolation and Real-Time PCR. All critical enzymes for the kits are produced internally. Those kits provide excellent yields and added convenience comparing to other products available on the market.

BLIRT’s experience and expertise in development of protein production methods (upstream and downstream), combined with its commercial protein production capacity, makes it an ideal choice for a full service CMO.

BLIRT has three sites in Poland: R&D site, Kits manufacturing facility, and protein production facility.

Cerbios is a swiss privately held company specialized in the development and manufacturing of chemical and biological APIs for its world-wide partners.

The exclusive R&D and manufacturing expertise is available to our Pharma partners needing to develop and scale-up NCE or NBE for clinical trials, registration and commercial purpose.

cGMP APIs made by Cerbios in its FDA inspected site in Switzerland are sold worldwide mainly to pharma companies including EU, USA and Japan.

Cerbios is specialized in Reduced Folates (world leader position) but also in the manufacturing of High Potency Active Ingredients (HPAPIs) with a series of Vitamin D derivatives requiring sophisticated production units with high containment levels.

Another core business is the research, development and production of Probiotics of Pharma quality.
On top of that, in the last 17 years, CERBIOS has acquired a vast experience with Recombinant Proteins from mammalian cells (CHO) based on a state-of-the-art platform.

Service for third parties in exclusive manufacturing is concentrated in the area of HPAPI and Recombinant Proteins.

Full CMC support is given to our customers in order to provide them with the supply of cGMP clinical batches, registration/validation material and commercial manufacturing. Paramount to that is the supply of all documentation required for a successful registration.